Benchmarking Phase 2 trial costs

Benchmarking Phase 2 trial costs

Phase 2 trial costs are difficult to model and benchmark. To illustrate, see below a histogram of 1,045 US-funded Phase 2 trials from a dataset assembled by Fast Data Science from various sources.

The median cost was $1,459,000 and the mean cost was $2,205,000. The standard deviation was $3,035,000.

Phase 2 Clinical trial funding

Above: histogram of Phase 2 clinical trial costs.

It’s often hard to interpret and model working with cost values directly, so it’s advantageous to perform a log transform.

Phase 2 Clinical trial funding

Above: histogram of Phase 2 clinical trial costs using a log 10 scale. You can use the button to toggle through the other phases.

Phase 2 costs can be difficult to benchmark because it is the “inflection point” of a drug’s life. In the log plot above, you can see a bimodal distribution.

The lower of the two modes may represent smaller “Phase 2a” pilot studies (we have not fully validated this hypothesis). These are focused on dosing and early signals of efficacy in a small, controlled group of patients.

The higher mode may correspond to the “Phase 2b” pivotal trials. They are larger, longer, and designed to look like mini-Phase 3 trials. A Phase 2b trial can involve hundreds of patients across multiple countries, causing the cost to spike into the tens of millions.

Benchmarking and reference class forecasting for your Phase 2 trial

At Fast Data Science, we are working on the next level of clinical trial cost benchmarking: reference class forecasting. For the trial that you want to benchmark for, we can use transformers and vector embeddings to identify similar trials from our database, and apply a correction for inflation.

The tool will display the estimated cost, a lower and upper bound, and the past trials that the cost estimate was based on.

Find out about trial cost benchmarking

Talk to us about your trial cost benchmarking

Get in touch if you would like to subscribe to the tool’s cost benchmarking module and drag and drop your trial protocols and generate benchmark estimates.

Activity based costing for your Phase 2 trial

As an alternative to cost benchmarking, you can model a trial cost, by identifying all activities associated with the trial (such as the assessments in the schedule of events), and sum these items to create a budget. This is complex and time consuming, but creates an itemised budget. The Clinical Trial Risk Tool allows you to build a site budget directly from the protocol PDF.

Above: the Clinical Trial Risk Tool lets you upload a protocol and will automatically check the protocol design against its checklist, as well as generating a site budget for you.

Upload your clinical trial protocol and create a budget with AI

Protocol to budget

Upload your clinical trial protocol in PDF form to the Clinical Trial Risk Tool and create an itemised per-patient and fixed costs budget using our charge masters, or upload your own charge master.

See also

References

  1. Theresia, Yiallourou, et al. “Cost Drivers and Predictive Modeling of Clinical Trial Costs: Analysis of 101 Global Health Trials.” VeriXiv 2.152 (2025): 152.
  2. DiMasi JA, Hansen RW, Grabowski HG: The price of innovation: New estimates of drug development costs. J. Health Econ. 2003; 22: 151–185.
  3. DiMasi JA, Grabowski HG, Hansen RW: Innovation in the pharmaceutical industry: New estimate of R&D costs. J. Health Econ. 2016; 47: 20–33
  4. Young R, Bekele T, Gunn A, et al.: Developing new health technologies for neglected diseases: A pipeline portfolio review and cost model. Gates Open Research. 2020; 2.
  5. Martin L, Hutchens M, Hawkins C, et al.: How much do clinical trials cost? Nat. Rev. Drug Discov. 2017; 16: 381–382